Elephas, Neuberg Diagnostics to Partner
Elephas Biosciences announced recently that Neuberg Diagnostics will become its commercial partner in India. According to a release, Neuberg will process tumor biopsy samples on the elive platform at its…
Category Archives: Biotech
SHINE Selected for Two DOE Projects
SHINE announced recently that it has been selected for the U.S. Department of Energy’s Genesis Mission, an initiative to double America’s scientific output through AI. In one project, SHINE will…
Promega Achieves 100% Renewable Electricity
Promega achieved 100% renewable electricity across all global operations, the company announced today through its 2026 Corporate Responsibility Report. “Our 100% renewable electricity reflects years of deliberate investment, from solar…
Elephas, Invitrocue to Partner
Elephas Biosciences Corporation and Invitrocue Pte. Ltd, have partnered to expand personalized oncology in Southeast Asia, the company announced recently. Invitrocue will serve as Elephas’ commercial partner for the elive…
Realta Fusion to Build HQ at OM Station
Realta Fusion will receive up to $55 million from the State of Wisconsin and the City of Madison to develop its corporate headquarters and fusion research facility at OM Station, the…
CeleramAb Develops Tech to Accelerate Data Analysis
CeleramAb, which markets reagent and software kits designed to help pharmaceutical companies analyze complex biological data more quickly, has developed a direct infusion technology that streamlines peptide mapping data collection…
SHINE, newcleo to Partner
SHINE has partnered with newcleo, a developer of advanced nuclear reactors and fuel, to advance innovative technologies for the recycling of used nuclear fuel, the company announced recently. According to…
SHINE Receives European Marketing OK for Illumira
SHINE Technologies’ Ilumira has received Centralized Marketing Authorization in Europe, the company announced today. “For years, our customers have asked for a reliable partner that can deliver both the diagnostic…
NorthStar, LIFT to Partner
NorthStar Medical Radioisotopes and the Low Institute for Therapeutics (LIFT), a non-profit clinical research organization, have entered a strategic collaboration to accelerate the development, manufacturing and clinical translation of Lu177-LT17,…
NorthStar, QSA Global to Partner
NorthStar Medical Radioisotopes has entered into a multi-year strategic services agreement with QSA Global, which specializes in radioactive source manufacturing and medical radiochemical services, the company announced today. According to…
